PGX-HIV

HIV pcr

  • Highly active retroviral therapy (HAART) has brought substantial HIV pcr improvements to HIV-positive patients and has led to a large reduction in AIDS-related mortality in countries where it became available. HIV pcr
  • Allelic variants of the multidrug transporter P-glycoprotein 1 (MDR1), cytochrome P450 isozyme 2D6, and the C-C chemokine receptor 5 are known to be associated with success of this therapy. HIV pcr
  • Identification of relevant genetic variations allows better guidance of HIV therapy.

Ordering information:

HIV pcr

Brochure PGX-HIV

Highly active retroviral therapy (HAART) has brought substantial  improvements to HIV-positive patients and has led to a large reduction in AIDS-related mortality in countries where it became available. HIV pcrAllelic variants of the multidrug transporter P-glycoprotein 1 (MDR1), cytochrome P450 isozyme 2D6, and the C-C chemokine receptor 5 are known to be associated with success of this therapy. Identification of relevant genetic variations allows better guidance of HIV therapy.Highly active retroviral therapy (HAART) has brought substantial improvements to HIV-positive patients and has led to a large reduction in AIDS-related mortality in countries where it became available. HIV pcrAllelic variants of the multidrug transporter P-glycoprotein 1 (MDR1), cytochrome P450 isozyme 2D6, and the C-C chemokine receptor 5 are known to be associated with success of this therapy. Identification of relevant genetic variations allows better guidance of HIV therap